×
返回 Agenda
Session1: Rare Disease
Session Chair(s)
Toshihiko Doi, MD, PhD
Deputy Director / Chief, Experimental Therapeutics
National Cancer Center Hospital East, Japan
Noboru Yamamoto, MD, PhD
Deputy Director, Department of Experimental Therapeutics
National Cancer Center Hospital, Japan
Speaker(s)
Lessons from Rare Cancers to Accelerate Therapeutic Development Globally
George D. Demetri, MD
Dana-Farber Cancer Institute, Inc., United States
Senior Vice President for Experimental Therapeutics
Treatment Development for Rare Cancers in Japan
Kenichi Nakamura, MD, PhD, MBA
National Cancer Center Hospital, Japan
Chief, Department of International Clinical Development
Sakigake of Cancer Genomic Medicine ~ Entrectinib ~
Morihiko Hayashi, DVM
Chugai Pharmaceutical Co., Ltd., Japan
Clinical Development, Clinical Science & Strategy